Upgrade to SI Premium - Free Trial

Piper Sandler Reiterates Overweight Rating on Medtronic, Inc. (MDT)

August 21, 2024 7:43 AM
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $90.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles